In some patients, a diagnosed
non-malignant tumor will transform into a malignant tumor,
which is a rare occurrence.
Malignant transformation of a non-malignant
tumor or progression of a non-malignant primary CNS tumor
to a malignant tumor can be determined from physician statements
in the patient medical record or by pathological review.
Pathologists develop a final diagnosis of malignant
transformation or progression from a non-malignant tumor by
review of old slides from previous biopsies, excisions of
the non-malignant tumor, or by review of the newly-biopsied
or -resected malignant brain tumor.
Malignant transformation and progression to
malignancy mean the same thing. A change in morphology in
a tumor from WHO grade I to WHO grade II, III, or IV indicates
malignant transformation. When malignant transformation occurs,
the tumors are considered separate primaries and two abstracts
are completed. Recording these as separate primaries will
allow researchers investigating these specific conditions
to identify cases.
Use the following table as a reference for determining
whether a new abstraction is needed.
Situation |
Create new abstract? |
| Benign /0 to borderline /1 |
No* |
| Benign /0 to malignant /3 |
Yes |
| Borderline /1 to malignant /3 |
Yes |
| Malignant /3 to malignant /3 |
No* |
| WHO Grade I to Grade II, III, or IV |
Yes |
| WHO Grade II to III or IV |
No* |
| WHO Grade III to IV |
No* |
| * Abstract as one primary using original
histology and note progression in remarks. |

|